Joseph Gelormini
Cardiovascular Disease · Buffalo, NYNPI 1790790442
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,072 of the $7,786 with a category attached, or 78.0%. 21 manufacturers reported payments, led by Boston Scientific at 27.2% of the total. Reporting peaked in 2019 at $5,147 and has fallen 97.5% since, to $128 in 2024.
Across 271 payments — averaging $28.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Abbott$2K
- Medtronic$917
- Abiomed$744
- Edwards Lifesciences$470
- Johnson & Johnson$299
- plus $1K from 15 others
Across 38 payments — averaging $2634.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$48K
- Bayer$42K
- AstraZeneca$8K
- Sanofi US Services Inc.$2K
What the payments were for
- Travel & lodging$1,57320%
- Food & beverage$6,07278%
- Education$1412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 107 | $2,121 |
| Abbott | 17 | $1,759 |
| Medtronic(2 entities) | 16 | $917 |
| Abiomed | 30 | $744 |
| Edwards Lifesciences | 11 | $470 |
| Johnson & Johnson | 19 | $299 |
| Amgen | 14 | $239 |
| Biotronik Inc. | 5 | $220 |
| Endologix LLC | 1 | $218 |
| Pfizer | 14 | $186 |
| Boehringer Ingelheim | 8 | $145 |
| Novartis | 8 | $141 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 6 | $84 |
| Sanofi-aventis U.S. LLC | 5 | $83 |
| Penumbra, Inc. | 3 | $55 |
| Merck | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
| Chiesi USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Mitra Clip system$1,105
- CoreValve Evolut$424
- Impella$365
- Alto Abdominal Stent Graft System$218
- XARELTO$115
How this compares
$7,786 in reported general payments places this provider in the 80th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in Buffalo
- Saurabh MalhotraBuffalo$438K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.